839 related articles for article (PubMed ID: 23832448)
1. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice.
Tomita K; Teratani T; Suzuki T; Shimizu M; Sato H; Narimatsu K; Okada Y; Kurihara C; Irie R; Yokoyama H; Shimamura K; Usui S; Ebinuma H; Saito H; Watanabe C; Komoto S; Kawaguchi A; Nagao S; Sugiyama K; Hokari R; Kanai T; Miura S; Hibi T
Hepatology; 2014 Jan; 59(1):154-69. PubMed ID: 23832448
[TBL] [Abstract][Full Text] [Related]
2. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
[TBL] [Abstract][Full Text] [Related]
3. Acyl-CoA:cholesterol acyltransferase 1 mediates liver fibrosis by regulating free cholesterol accumulation in hepatic stellate cells.
Tomita K; Teratani T; Suzuki T; Shimizu M; Sato H; Narimatsu K; Usui S; Furuhashi H; Kimura A; Nishiyama K; Maejima T; Okada Y; Kurihara C; Shimamura K; Ebinuma H; Saito H; Yokoyama H; Watanabe C; Komoto S; Nagao S; Sugiyama K; Aosasa S; Hatsuse K; Yamamoto J; Hibi T; Miura S; Hokari R; Kanai T
J Hepatol; 2014 Jul; 61(1):98-106. PubMed ID: 24657401
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.
Yu J; Zhang S; Chu ES; Go MY; Lau RH; Zhao J; Wu CW; Tong L; Zhao J; Poon TC; Sung JJ
Int J Biochem Cell Biol; 2010 Jun; 42(6):948-57. PubMed ID: 20156580
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
[TBL] [Abstract][Full Text] [Related]
6. Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis.
Shirai Y; Yoshiji H; Noguchi R; Kaji K; Aihara Y; Douhara A; Moriya K; Namisaki T; Kawaratani H; Fukui H
J Gastroenterol Hepatol; 2013 Apr; 28(4):723-30. PubMed ID: 23301938
[TBL] [Abstract][Full Text] [Related]
7. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis.
Uno M; Kurita S; Misu H; Ando H; Ota T; Matsuzawa-Nagata N; Kita Y; Nabemoto S; Akahori H; Zen Y; Nakanuma Y; Kaneko S; Takamura T
Hepatology; 2008 Jul; 48(1):109-18. PubMed ID: 18571789
[TBL] [Abstract][Full Text] [Related]
8. Vitamin A-coupled liposome system targeting free cholesterol accumulation in hepatic stellate cells offers a beneficial therapeutic strategy for liver fibrosis.
Furuhashi H; Tomita K; Teratani T; Shimizu M; Nishikawa M; Higashiyama M; Takajo T; Shirakabe K; Maruta K; Okada Y; Kurihara C; Watanabe C; Komoto S; Aosasa S; Nagao S; Yamamoto J; Miura S; Hokari R
Hepatol Res; 2018 Apr; 48(5):397-407. PubMed ID: 29243365
[TBL] [Abstract][Full Text] [Related]
9. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
Luo XY; Takahara T; Kawai K; Fujino M; Sugiyama T; Tsuneyama K; Tsukada K; Nakae S; Zhong L; Li XK
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
Nan YM; Fu N; Wu WJ; Liang BL; Wang RQ; Zhao SX; Zhao JM; Yu J
Scand J Gastroenterol; 2009; 44(3):358-65. PubMed ID: 18991162
[TBL] [Abstract][Full Text] [Related]
11. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
[TBL] [Abstract][Full Text] [Related]
12. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
[TBL] [Abstract][Full Text] [Related]
13. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.
Ni XX; Li XY; Wang Q; Hua J
J Physiol Biochem; 2021 Feb; 77(1):35-45. PubMed ID: 33188625
[TBL] [Abstract][Full Text] [Related]
14. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.
Twu YC; Lee TS; Lin YL; Hsu SM; Wang YH; Liao CY; Wang CK; Liang YC; Liao YJ
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420058
[TBL] [Abstract][Full Text] [Related]
15. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T
Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.
Nan YM; Han F; Kong LB; Zhao SX; Wang RQ; Wu WJ; Yu J
Scand J Gastroenterol; 2011 Mar; 46(3):358-69. PubMed ID: 20969493
[TBL] [Abstract][Full Text] [Related]
17. Hepatic endothelin-1 and endocannabinoids-dependent effects of hyperleptinemia in nonalcoholic steatohepatitis-cirrhotic rats.
Yang YY; Tsai TH; Huang YT; Lee TY; Chan CC; Lee KC; Lin HC
Hepatology; 2012 May; 55(5):1540-50. PubMed ID: 22183953
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-like protein 4 deficiency augments liver fibrosis in liver diseases such as nonalcoholic steatohepatitis in mice through enhanced free cholesterol accumulation in hepatic stellate cells.
Teratani T; Tomita K; Wada A; Sugihara N; Higashiyama M; Inaba K; Horiuchi K; Hanawa Y; Nishii S; Mizoguchi A; Tanemoto R; Ito S; Okada Y; Kurihara C; Akita Y; Narimatsu K; Watanabe C; Komoto S; Oike Y; Miura S; Hokari R; Kanai T
Hepatol Res; 2021 May; 51(5):580-592. PubMed ID: 33247991
[TBL] [Abstract][Full Text] [Related]
19. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.
Velayudham A; Dolganiuc A; Ellis M; Petrasek J; Kodys K; Mandrekar P; Szabo G
Hepatology; 2009 Mar; 49(3):989-97. PubMed ID: 19115316
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
